Advertisement
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Acacia Research Corporation announced today that a subsidiary has acquired patents for inhaler drug delivery technology from a major medical company.

"Acacia continues to increase the number of patent portfolios we control in the medical technology sector," commented Paul Ryan, CEO. "Acacia is rapidly expanding its presence as a leader in patent licensing for both the technology and medical technology sectors."

ABOUT ACACIA RESEARCH CORPORATION

Acacia Research Corporations subsidiaries partner with inventors and patent owners, license the patents to corporate users, and share the revenue. Acacia Research Corporations subsidiaries control over 200 patent portfolios, covering technologies used in a wide variety of industries. Information about Acacia Research Corporation and its subsidiaries is available at www.acaciaresearchgroup.com and www.acaciaresearch.com.

Posted by Sean Fenske, Editor-in-Chief, MDT

Advertisement
Advertisement